4
Changes in Ownership
Passage BIO, Inc. Filed Acc 0001415889-24-003637
CHIEF MEDICAL OFFICER sold 1,638 shares at $0.97 ($1,589)
- CHIEF MEDICAL OFFICER acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Forman Mark S CHIEF MEDICAL OFFICER | 2024-02-10 | Option exercise | +5,000 | 50,269 | D | ||
| Forman Mark S CHIEF MEDICAL OFFICER | 2024-02-13 | Sale | −1,638 | $0.97 | $1,589 | 48,631 | D |
| Derivatives | |||||||
| Forman Mark S CHIEF MEDICAL OFFICER | 2021-08-16 | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | D | ||
| Forman Mark S CHIEF MEDICAL OFFICER | 2022-02-10 | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | D | ||
| Forman Mark S CHIEF MEDICAL OFFICER | 2022-02-10 | Grant or award · Restricted Stock Unit | +15,000 | 15,000 | D | ||
| Forman Mark S CHIEF MEDICAL OFFICER | 2024-02-10 | Option exercise · Restricted Stock Unit | −5,000 | 10,000 | D | ||
| Open-market sales · 1,638 sh · avg $0.97 · $1,589 | |||||||
Loading xslF345X05/form4-02142024_120249.xml…